
Novel Agents & Clinical Trials 2017
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
Dr. Craig Cole (University of Michigan Comprehensive Cancer Center) gives an update on the novel agents currently used to treat multiple myeloma and how clinical trials benefit patients.
This teleconference is sponsored by an educational grant from:
Celgene Corporation and Janssen
Previous Post
What diet do you recommend?
Next Post
Is a low white blood cell count common in smoldering multiple myeloma?